CJC-1295/Ipamorelin Blend 5 mg + 10 mg

CJC-1295/Ipamorelin Blend 5 mg + 10 mg

Research Peptide

CJC-1295 (no DAC) + Ipamorelin Combination CJC-1295 (no DAC) 5mg + Ipamorelin 10mg — Research-Grade GHRH/GHS-R Synergistic GH Secretagogue Blend

Document ID: HKPW-cjc-1295-without-dac-5-mg-ipa-10-mg-rese-v1.0 | Reviewed by: HKPEPTIDE WORLDWIDE Research Team | Last Updated: 2026-08-08

Product Identity & Specifications

ParameterSpecification
Product NameCJC-1295 (no DAC) + Ipamorelin Combination
DosageCJC-1295 (no DAC) 5mg + Ipamorelin 10mg
CAS Number863288-34-0 / 170851-70-4
Molecular FormulaC₁₅₂H₂₅₂N₄₄O₄₂ / C₃₈H₄₉N₉O₅
Molecular Weight~3,367.1 / ~711.9 Da
SequenceCJC-1295: GHRH analogue
Purity≥99% HPLC
AppearanceWhite to off-white lyophilized powder
SolubilitySoluble in sterile water or bacteriostatic water
Storage2–8°C, desiccated, protected from light
ClassificationGHRH/GHS-R Synergistic GH Secretagogue Blend

Research Background

The CJC-1295 (no DAC) + Ipamorelin blend is the most studied GH secretagogue combination in preclinical research. CJC-1295 provides sustained GHRH receptor activation (the GH “on” switch), while Ipamorelin suppresses somatostatin tone through selective GHS-R1a agonism (removing the GH “off” switch). Together, they produce a synergistic GH pulse exceeding the additive effect of either peptide alone. The no-DAC CJC-1295 variant (~30 minute half-life) is specifically chosen for this blend to produce discrete, physiological GH pulses rather than sustained elevation. Each peptide is individually verified before combination, and the kit ships with unified COA documentation.

The CJC-1295 (no DAC) 5mg + Ipamorelin 10mg configuration is manufactured under strict quality control protocols. Each batch undergoes HPLC purity verification, ESI-MS identity confirmation, and amino acid analysis. A batch-specific Certificate of Analysis (COA) is included with every order. Bulk and OEM configurations available for qualifying wholesale accounts.

Molecular Mechanisms

GHRH Signal (CJC-1295)

GHRH-R activation on pituitary somatotrophs → cAMP/PKA → GH synthesis and vesicle mobilization. The no-DAC variant produces ~30 minute GHRH-R activation → discrete, physiological GH pulse.

Somatostatin Suppression (Ipamorelin)

Selective GHS-R1a activation → reduced hypothalamic somatostatin tone → removal of tonic GH inhibition. Ipamorelin’s selectivity minimizes ACTH/cortisol and hunger off-target effects.

Synergistic GH Pulse

GHRH signal + somatostatin suppression → amplified GH release. GHRH opens the gate; GHS-R removes the brake. The resulting GH pulse is larger than either peptide alone and closely mimics endogenous pulsatile secretion.

Research Applications

  • Pulsatile GH Secretion Research
  • GHRH/GHS-R Synergy Studies
  • Body Composition Research
  • Exercise-Induced GH Window Studies

Comparative Analysis

Compared to CJC-1295 (DAC) + Ipamorelin: The no-DAC blend produces discrete physiological GH pulses (~30 min). The DAC blend produces sustained GH elevation (~8 days). Choice depends on whether the research objective is pulsatile (no DAC) or sustained (DAC) GH signaling.

Quality Control & Analytical Specifications

ParameterMethodSpecification
PurityHPLC at 214 nm, C18 column≥99.0% peak area
Identity (MW)ESI-MS~3,367.1 / ~711.9 Da
AppearanceVisual inspectionWhite to off-white powder
Peptide ContentAmino acid analysis≥80% net peptide
Residual MoistureKarl Fischer titration≤3%
EndotoxinLAL assay≤0.5 EU/mg

Available Configurations

ConfigurationContentBest For
Standard KitCJC-1295 (no DAC) 5mg + Ipamorelin 10mg × 10 vialsEvaluation; protocol validation
Bulk KitCustom × 10 vialsChronic studies; repeat orders
OEM/Private LabelCustomBranded product development

Frequently Asked Questions

Q: Why pair CJC-1295 with Ipamorelin?

CJC-1295 provides the GHRH signal (GH ‘on’ switch). Ipamorelin suppresses somatostatin (removes GH ‘off’ switch). Together: synergistic GH pulse larger than either alone. Most studied GH secretagogue combination.

Q: Why no-DAC CJC-1295 for this blend?

No DAC = ~30 min half-life = discrete, physiological GH pulse. DAC variant = ~8 day half-life = sustained GH. Pulsatile protocols prefer no DAC; chronic elevation protocols prefer DAC.

Q: What documentation is provided?

Unified COA: individual HPLC purities, individual ESI-MS identities, combined kit batch number. Individual peptide COAs available on request.

Tiered Wholesale Pricing

VolumeDiscountFor
1 kitList priceEvaluation; competitive analysis
5+ kits10% offInitial portfolio expansion
20+ kits20% offMid-size distributors
50+ kits30% offRegional distributors

Contact our team for 100+ kit custom pricing. Mixed-molecule orders qualify for combined volume tiers.

ResourceDescription
Healing Regenerative Peptides HubComplete research overview & methodology hub
Cjc 1295 With Dac 10 Mgin Vitro ResearchRelated research peptide product
Cjc 1295 With Dac 2 Mg Laboratory ResearRelated research peptide product
Why Muscle Growth Peptide Research Is ExpandingLatest research insights & methodology

View Complete Research Guide »

Compliance Statement

FOR LABORATORY RESEARCH USE ONLY. Not for human or veterinary diagnostic, therapeutic, or prophylactic use. Not a dietary supplement, pharmaceutical ingredient, or approved drug. Researchers must comply with all applicable institutional, local, and national regulations.


© 2026 HKPEPTIDE WORLDWIDE. All rights reserved. Document ID: HKPW-cjc-1295-without-dac-5-mg-ipa-10-mg-rese-v1.0